APIS Health Angels Logo
For Investors
For Startups
Events & Workshops
About Us
Resources
Account options (Coming Soon)
My Account (coming soon)
Connect with us
Account options (Coming Soon)
My Account (coming soon)
Connect with us
Account options (Coming Soon)
My Account (coming soon)
Connect with us
Account options (Coming Soon)
My Account (coming soon)
Connect with us
Account options (Coming Soon)
My Account (coming soon)
Connect with us

Inaugural Cohort One Announces Investment Winner Dr. Greg Grover and Karios Technologies

04-08-2022
With an innovative adhesion prevention treatment goal, Karios Technologies wins the Apis Health Angels Conference.

With 6 successful finalists pitching for the final investment, the Apis Health Angels selected CEO, Co-Inventor, & Co-Founder of Karios Technologies, Inc. Dr. Gregory Grover for the investment. Houston-based Karios Technologies won the inaugural Apis Health Angel Conference, launched in Seattle to connect investors and health-related startups.

Follow the GeekWire article for more coverage.

The program is modeled after the Seattle Angel Conference, which has educated investors and funded companies for more than ten years through its startup competition.

More than 50 companies started with the Apis cohort late last year, and six made it to the final competition Thursday evening. They presented pitches to more than 25 participating angel investors.

The Apis conference is virtual and accepted applicants from all over the country. The investors each contributed $5,000 to the winner’s pool. Karios took home a minimum of $145,000.

RELATED: Seattle Angel Conference launches new health startup competition to help educate angel investors.

Karios is developing a way to help prevent tissue adhesions after surgery, using hydrogel technology spun out of the University of California Los Angeles and UC San Diego. The startup is focused on children with congenital heart defects.

“Our passion is to bring this product into clinic to improve the quality of life of these young patients and then transition in other high impact areas of surgery,” said CEO Gregory Grover in a statement. Grover was previously a bioengineering postdoctoral fellow at UCSD and has held senior positions at biotech and medical device companies.

A three way tie for Audience Favorite Award included Karios Technologies as well as:

NanoPharmaSolutions, which offers technology to help formulate biopharmaceuticals and is based in San Diego led by founder Kay Olmstead.

Remedium Bio, a Needham, Mass.-based biotech company developing gene therapies for a broad range of conditions particularly focused on osteoarthritis of the knee with CEO Frank Luppino.

Newsletter Signup
Sign up for our newsletter to receive the latest news on APIS Health Angels, valuable information for startups seeking funding, and education for new and experienced angel investors.
Sign up

Latest Articles and Updates

Follow us on social media:
Sign up for our newsletter
Copyright © 2022 Mossy Ventures
Website Development and SEO by Symphysis